Prospective randomised concurrent comparison of the COBE Spectra Version 4.7, COBE Spectra Version 6 (Auto PBSC™), and Haemonetics MCS+ cell separators for leucapheresis in patients with haematological and non haematological malignancies

Prospective, concurrent comparison of th

Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS-3P cell separators for leukapheresis after high-dose filgrastim in patients with hematologic malignancies

✍ Jayesh Mehta; Ray Powles; Jennie Treleaven; Barbara Millar; Helen Proctor; Sandr 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

A prospective study was undertaken to compare the mononuclear cell, CD34+ cell, and CFU-GM yields of the Haemonetics MCS-3P and the Cobe Spectra cell separators in ten patients (nine multiple myeloma and one non-Hodgkin lymphoma) on two consecutive days after mobilization with high-dose filgrastim (